DNA SEQUENCING – NGS (Somatic SNVs and indels + matched germline sample)
Applicable to any lab using requiring a matched normal control germline sample as part of their somatic NGS testing process. Pilot EQA.
Homologous Recombination Deficiency (HRD) testing in ovarian cancer [Tissue]
Applicable to all labs undertaking molecular genetic testing for HRD in solid tumours.
Inherited Retinal Disorders (IRD)
Applicable to all labs undertaking molecular genetic testing for syndromic and non-syndromic IRD.
cfDNA extraction from plasma (Round 1)
Applicable for all labs extracting cfDNA from plasma. Two rounds of EQA per year – purchase each separately.
This EQA will be distributed in MARCH 2025.
cfDNA extraction from plasma (Round 2)
Applicable for all labs extracting cfDNA from plasma. Two rounds of EQA per year – purchase each separately.
This EQA will be distributed in SEPTEMBER 2025.
Pan-Tumour Fusions [FFPE]
Applicable to all labs undertaking molecular genetic testing for this fusion genes in solid tumours.
